Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE).
Wolf J, Kalocsai K, Fortuny C, Lazar S, Bosis S, Korczowski B, Petit A, Bradford D, Croos-Dabrera R, Incera E, Melis J, van Maanen R. Wolf J, et al. Among authors: fortuny c. Clin Infect Dis. 2020 Dec 17;71(10):2581-2588. doi: 10.1093/cid/ciz1149. Clin Infect Dis. 2020. PMID: 31773143 Free PMC article. Clinical Trial.
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen.
Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, Comerma L, Chorny A, Shan M, Xu W, Magri G, Knowles DM, Tam W, Chiu A, Bussel JB, Serrano S, Lorente JA, Bellosillo B, Lloreta J, Juanpere N, Alameda F, Baró T, de Heredia CD, Torán N, Català A, Torrebadell M, Fortuny C, Cusí V, Carreras C, Diaz GA, Blander JM, Farber CM, Silvestri G, Cunningham-Rundles C, Calvillo M, Dufour C, Notarangelo LD, Lougaris V, Plebani A, Casanova JL, Ganal SC, Diefenbach A, Aróstegui JI, Juan M, Yagüe J, Mahlaoui N, Donadieu J, Chen K, Cerutti A. Puga I, et al. Among authors: fortuny c. Nat Immunol. 2011 Dec 25;13(2):170-80. doi: 10.1038/ni.2194. Nat Immunol. 2011. PMID: 22197976 Free PMC article.
Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4.
Leung DH, Wirth S, Yao BB, Viani RM, Gonzalez-Peralta RP, Jonas MM, Lobritto SJ, Narkewicz MR, Sokal E, Fortuny C, Hsu EK, Del Valle-Segarra A, Zha J, Larsen L, Liu L, Shuster DL, Cohen DE, Rosenthal P. Leung DH, et al. Among authors: fortuny c. Hepatol Commun. 2018 Oct 5;2(11):1311-1319. doi: 10.1002/hep4.1250. eCollection 2018 Nov. Hepatol Commun. 2018. PMID: 30411078 Free PMC article.
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years.
Turkova A, Chan MK, Kityo C, Kekitiinwa AR, Musoke P, Violari A, Variava E, Archary M, Cressey TR, Chalermpantmetagul S, Sawasdichai K, Ounchanum P, Kanjanavanit S, Srirojana S, Srirompotong U, Welch S, Bamford A, Epalza C, Fortuny C, Colbers A, Nastouli E, Walker S, Carr D, Conway M, Spyer MJ, Parkar N, White I, Nardone A, Thomason MJ, Ferrand RA, Giaquinto C, Ford D; D3 trial team. Turkova A, et al. Among authors: fortuny c. Contemp Clin Trials. 2024 Jul;142:107540. doi: 10.1016/j.cct.2024.107540. Epub 2024 Apr 16. Contemp Clin Trials. 2024. PMID: 38636725 Free article. Clinical Trial.
Serological Outcome in the First Months of Life of Children Born to Mothers with SARS-CoV-2 Infection during Pregnancy.
Pons-Tomàs G, Martínez-de-Albeniz I, Ríos-Barnés M, Gamell A, Simó-Nebot S, Balsells-Mejía S, Hernández-García M, Melé-Casas M, Sánchez E, Monsonis M, Gené A, López M, Salvia D, Garcia-García JJ, Fortuny C, Fumadó V. Pons-Tomàs G, et al. Among authors: fortuny c. Children (Basel). 2024 Sep 6;11(9):1095. doi: 10.3390/children11091095. Children (Basel). 2024. PMID: 39334627 Free PMC article.
Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations.
Pons-Tomàs G, Pino R, Soler-García A, Launes C, Martínez-de-Albeniz I, Ríos-Barnés M, Melé-Casas M, Hernández-García M, Monsonís M, Gené A, de-Sevilla MF, García-García JJ, Fortuny C, Fumadó V. Pons-Tomàs G, et al. Among authors: fortuny c. Pathogens. 2024 Jul 26;13(8):622. doi: 10.3390/pathogens13080622. Pathogens. 2024. PMID: 39204223 Free PMC article.
Off-label use of dalbavancin in children: a case series.
Gamell A, Velasco-Arnaiz E, López-Ramos MG, Ríos-Barnés M, Simó-Nebot S, Fumadó V, Noguera-Julián A, Fortuny C. Gamell A, et al. Among authors: fortuny c. J Antimicrob Chemother. 2024 Aug 1;79(8):2062-2067. doi: 10.1093/jac/dkae212. J Antimicrob Chemother. 2024. PMID: 38958260 Free PMC article.
Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study.
Agüera M, Soler-Garcia A, Alejandre C, Moussalam-Merino S, Sala-Castellví P, Pons G, Penela-Sánchez D, González-Grado C, Alsina-Rossell J, Climent C, Esteva C, Fortuny C, de-Sevilla MF, García-García JJ, Brotons P, Balaguer A, Estrada J, Jordan I, Muñoz-Almagro C, Launes C. Agüera M, et al. Among authors: fortuny c. Pediatr Allergy Immunol. 2024 Jun;35(6):e14175. doi: 10.1111/pai.14175. Pediatr Allergy Immunol. 2024. PMID: 38899631
180 results